We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ELE:BMEEndesa S.A. Analysis

Data as of 2026-05-26 - not real-time

$16.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ELE is trading at $16.78, below its 20‑day SMA of $17.63 and 200‑day SMA of $17.57, indicating short‑term weakness. RSI sits around 43, suggesting the stock is neither oversold nor overbought, while the MACD histogram is negative, reinforcing a bearish technical bias. Volume has been decreasing, which may limit upside momentum in the near term. The stock’s beta of 1.43 and a 30‑day volatility of roughly 75% point to heightened price swings relative to the market. On the valuation side, a trailing PE of 279x looks extreme, but the forward PE of 26.8x and a DCF‑derived fair value of about $17.9 suggest modest undervaluation at current levels. The dividend yield of 0.72% appears unsustainable given a negative profit margin and a free cash flow deficit, despite the company’s sizable cash pile of $85.9 M.
Analysts are bullish, assigning a “strong buy” rating and a median price target of $29.75, implying significant upside potential. The royalty model provides high gross margins (≈95%) and exposure to precious‑metal price appreciation, which could drive earnings growth in the medium to long term. However, the current negative earnings and free cash flow underscore the need for caution. The strong balance sheet and zero‑debt profile mitigate some risk, but the combination of high volatility, bearish short‑term technicals, and earnings weakness suggests a wait‑and‑see approach before committing larger capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Decreasing trading volume
  • Price below short‑term SMA levels

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE of ~27x indicating earnings improvement
  • DCF fair value slightly above current price
  • Analyst median target of $29.75

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong cash position with zero debt
  • Royalty exposure to rising precious‑metal prices
  • Diversified geographic asset base

Key Metrics & Analysis

Financial Health

Revenue Growth109.00%
Profit Margin-1.05%
P/E Ratio279.7
ROE-0.12%
ROA1.13%
P/B Ratio1.4
Op. Cash Flow$42.9M
Free Cash Flow$-28043876

Technical Analysis

TrendNeutral
RSI43.5
Support$15.68
Resistance$20.64
MA 20$17.63
MA 50$18.55
MA 200$17.57
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Fair Value$17.94
Target Price$29.75
Upside/Downside77.29%
GradeFair
TypeBlend
Dividend Yield0.72%

Risk Assessment

Beta1.43
Volatility75.43%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.